News Second vCJD patient to receive experimental treatment BMJ 2003; 327 doi: https://doi.org/10.1136/bmj.327.7420.886-a (Published 16 October 2003) Cite this as: BMJ 2003;327:886 Article Related content Metrics Responses Peer review Related articles News NIH announces new strategy for research Published: 02 October 2003; BMJ 327 doi:10.1136/bmj.327.7418.765 News Small improvement seen in teenager with vCJD Published: 02 October 2003; BMJ 327 doi:10.1136/bmj.327.7418.765-a News Roundup [abridged Versions Appear In The Paper Journal] Trials for vCJD treatment held up because of disagreements Published: 06 November 2003; BMJ 327 doi:10.1136/bmj.327.7423.1069 See more Sixty seconds on . . . greening the NHS BMJ February 02, 2016, 352 i605; DOI: https://doi.org/10.1136/bmj.i605 Peptides that form amyloid plaques in Alzheimer’s may be transmissible, study finds BMJ September 10, 2015, 351 h4831; DOI: https://doi.org/10.1136/bmj.h4831 Naturally occurring genetic variation that prevents prion disease is identified BMJ June 12, 2015, 350 h3186; DOI: https://doi.org/10.1136/bmj.h3186 Food and the responsibility deal: how the salt reduction strategy was derailed BMJ April 28, 2015, 350 h1936; DOI: https://doi.org/10.1136/bmj.h1936 Government pledges to assess risk of vCJD transmission BMJ October 20, 2014, 349 g6350; DOI: https://doi.org/10.1136/bmj.g6350